申请人:Revolution Medicines, Inc.
公开号:US20210130303A1
公开(公告)日:2021-05-06
The disclosure features macrocyclic compounds, and pharmaceutical compositions and protein complexes thereof, capable of inhibiting Ras proteins, and their uses in the treatment of cancers.
该披露涉及大环化合物,以及能够抑制Ras蛋白并用于治疗癌症的制药组合物和蛋白复合物。